Get the Stockscreener App
57.58
1.52%
-0.89
After Hours:
57.58
Rhythm Pharmaceuticals Inc Stock (RYTM) Latest News
Research Analysts Set Expectations for RYTM FY2029 Earnings - Defense World
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
abrdn plc Reduces Stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - MarketBeat
Insider Selling: Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) CFO Sells 1,678 Shares of Stock - MarketBeat
Jennifer Kayden Lee Sells 1,447 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Stock - MarketBeat
Joseph Shulman Sells 1,281 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Stock - MarketBeat
Long Term Trading Analysis for (RYTM) - Stock Traders Daily
KBC Group NV Buys 988 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World
Insider Selling: Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) CEO Sells 4,278 Shares of Stock - MarketBeat
JGP Global Gestao de Recursos Ltda. Has $301,000 Stock Position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - MarketBeat
RYTMRhythm Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan
RYTM (Rhythm Pharmaceuticals) Enterprise Value : $3,390.0 Mil (As of Feb. 05, 2025) - GuruFocus.com
Rhythm Pharmaceuticals to Present at Oppenheimer Annual Healthcare Life Sciences Conference in February - GlobeNewswire
Strength Seen in Rhythm Pharmaceuticals (RYTM): Can Its 7.4% Jump Turn into More Strength? - MSN
An Analysis of Rhythm Pharmaceuticals Inc (RYTM)’s Potential Price Growth - Knox Daily
A History of Outperforming Analyst Forecasts and Beating the Odds: Rhythm Pharmaceuticals Inc (RYTM) - SETE News
Nisa Investment Advisors LLC Sells 64,955 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - MarketBeat
Rhythm Pharmaceuticals: Promising Weight Loss Breakthroughs and Strategic Advancements Justify Buy Rating - TipRanks
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Shares Sold by Nisa Investment Advisors LLC - Defense World
Wall Street Analysts Think Rhythm Pharmaceuticals (RYTM) Could Surge 26.36%: Read This Before Placing a Bet - Yahoo Finance
How To Trade (RYTM) - Stock Traders Daily
Soligenix (NASDAQ:SNGX) & Rhythm Pharmaceuticals (NASDAQ:RYTM) Head to Head Contrast - Defense World
Rhythm Pharmaceuticals (RYTM) Soars 5.5%: Is Further Upside Left in the Stock? - MSN
Earnings call transcript: Rhythm Pharmaceuticals Q3 2024 sees growth - MSN
Rhythm Pharmaceuticals (NASDAQ:RYTM) Sees Large Volume IncreaseStill a Buy? - MarketBeat
Exploring High Growth Tech Stocks in January 2025 - Simply Wall St
Earnings call transcript: Rhythm Pharmaceuticals Q3 2024 sees growth By Investing.com - Investing.com Canada
Subdued Growth No Barrier To Rhythm Pharmaceuticals, Inc.'s (NASDAQ:RYTM) Price - Simply Wall St
JPMorgan Chase & Co. Sells 58,554 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives $68.09 Average Target Price from Analysts - Defense World
Head to Head Review: ABVC BioPharma (NASDAQ:ABVC) vs. Rhythm Pharmaceuticals (NASDAQ:RYTM) - Defense World
Rhythm gets FDA approval for Imcivree for toddlers - MSN
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Harbor Capital Advisors Inc. Sells 11,116 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - MarketBeat
Rhythm Pharmaceuticals (NASDAQ: RYTM) Reports Strong Growth in Revenue and Clinical Development Initiatives - Defense World
Rhythm Pharmaceuticals price target raised to $60 from $58 at BofA - MSN
Rhythm Pharmaceuticals, Inc. Provides Preliminary Revenue Guidance for the Fourth Quarter and Full Year of 2024 - Marketscreener.com
Rhythm Pharmaceuticals Reports Growth and Expands Pipeline - TipRanks
2.27%
5.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):